Literature DB >> 16278287

The impact of anti-TNF-alpha therapy on the nature of service provision.

D J Armstrong, E M A McCausland, G D Wright.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16278287     DOI： 10.1093/rheumatology/kei127

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  3 in total

1.  A feasibility study for a randomised controlled trial of treatment withdrawal in psoriatic arthritis (REmoval of treatment for patients in REmission in psoriatic ArThritis (RETREAT (F)).

Authors:  Anna Moverley; Laura Coates; Helena Marzo-Ortega; Robin Waxman; David Torgerson; Kim Cocks; Judith Watson; Philip S Helliwell
Journal:  Clin Rheumatol       Date:  2015-02-03       Impact factor: 2.980

2.  The funding and use of high-cost medicines in Australia: the example of anti-rheumatic biological medicines.

Authors:  Christine Y Lu; Kenneth M Williams; Richard O Day
Journal:  Aust New Zealand Health Policy       Date:  2007-03-01

3.  Retrospective Analysis of the Impact of Adalimumab Initiation on Corticosteroid Utilization and Medical Costs Among Biologic-Naïve Patients with Rheumatoid Arthritis.

Authors:  Christina A Spivey; Kevin L Winthrop; Jenny Griffith; Cameron M Kaplan; Yanru Qiao; Arnold E Postlethwaite; Junling Wang
Journal:  Rheumatol Ther       Date:  2019-11-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.